Environment Monitoring, Result Evaluation and Common Contaminants Study of Vaccine Manufacturing Facility
Environment Monitoring, Result Evaluation and Common Contaminants Study of Vaccine Manufacturing Facility
Environment Monitoring, Result Evaluation and Common Contaminants Study of Vaccine Manufacturing Facility
https://doi.org/10.22214/ijraset.2020.31965
International Journal for Research in Applied Science & Engineering Technology (IJRASET)
ISSN: 2321-9653; IC Value: 45.98; SJ Impact Factor: 7.429
Volume 8 Issue X Oct 2020- Available at www.ijraset.com
Abstract: Assurance of the sterile manufactured products can be given by carefully designed and executed environmental
monitoring (EM) program. State of control in an aseptic manufacturing process reveals one of the most important factors that is
environmental monitoring. For the release of the sterile production batch/ in the sterile product release process or procedure,
environmental monitoring results are decision making consideration. Environmental monitoring describes the microbiological
testing undertaken in order to detect changing trends of microorganism’s growth within the clean rooms or controlled
environments. Satisfactory results of the environmental monitoring provide the consistent and successful performance of the
physical construction of the cleanroom, Heat ventilation and air conditioning (HVAC) system, personnel behaviour and
performance in cleanroom, aseptic and clean gowning practices, equipment, aseptic and cleanroom operations. Veterinary
vaccine manufacturing facility consists of various virus strains, bacterial cultures and tissue cultures in same premises. The
objective of the present work was to perform the environment monitoring of the veterinary vaccine manufacturing facility using
the various sampling methods, to identify the environment isolates by morphological and biochemical tests which could be either
normal or any abnormal novel flora found in the environment of the veterinary vaccine manufacturing facility which could
hamper product quality drastically and to prepare the common environment isolate data bank to use as a guide to keep the
environment under control as per regulatory requirement for the veterinary vaccine safety, integrity, strength, purity and quality.
Keywords: EM, Environment Monitoring, Contamination, Cleanroom
I. INTRODUCTION
The Indian veterinary vaccine market has reached 107 million dollar in 2011 and its forecast to reach 174 million dollar by 2020
with a CAGR of 5%[1]. Veterinary vaccines fall in the category of the schedule C & C1 of the Drugs and Cosmetic Acts 1940,
Biological and Special Products, so these products must be manufactured under the cGMP manufacturing facility [2]. Indian
Pharmacopeia published in 2018 contains total 14 number of veterinary monographs along with the other monographs by the joint
efforts of Indian Federation of Animal Health Companies (INFAH) and Indian Pharmacopeia commission (IPC) to have the
standards for veterinary drugs shall as goods as human drugs.
Veterinary vaccine formulations are sterile parenteral formulations in which environment monitoring plays critical role in
maintenance of the sterility assurance level of the vaccine product manufactured. For veterinary vaccine industry, sterile product
batches are wasted and the plant shutdowns when microbiological contamination occurs. Such contamination leads to loss of
invested money, time of manufacturer, product delays, shortages or unavailability and loss of customer’s confidence. The
microbiological quality of drugs and biologics is very necessary for their effectiveness and end user’s safety. Additionally,
microorganisms can change the composition and pharmacology of drugs with adverse effect on their effectiveness due to the
breakdown of active ingredients as well as on their safety due to the toxicity of potential degradation of products. There are
substantial evidences including the warning letters, alert notifications and failures establishing a direct relationship between the level
of environmental control and the final quality of the product environmental control is a major concern in sterile vaccine
manufacturing.
It is challenging task to have the efficient design of the environment programme, execution of the programme, evaluation of its
results, to understand the trend of the normal and abnormal microorganism, to have the data bank of the environment isolates for
control reference. In this article we have selected one of the aseptic areas of the veterinary vaccine manufacturing facility for which
environment monitoring programme was executed. Different sampling techniques at various frequencies were used and results were
observed and evaluated from the environment monitoring.
According to the FDA (Food and Drug Administration) guidance for industry, viable monitoring is to be done where highest risk of
the contamination to the product exists. Therefore clean rooms and clean air devices should be routinely monitored during
operation. Environmental monitoring locations must be based on risk assessment and the results obtained during the classification of
rooms [3].
One must be aware about the potential sources of contamination in the environment to find out the location for the environment
study and to make trend for such microorganisms [4].
1) Active air Sampling: Active air sampling was done by the Air sampler, AES laboratories make, model AESAP1075, using
SCDA (Soyabean casein digest agar) plates. In air sampler, air sample is to be drawn through slits and to agar surface and by
controlled air flow, maximum impingement of air sample from various location is done. After completion of air sampling, plates
were incubated for 72 hours at 20-25 oC and then for 48 hours at 48 hours at 30°C - 35°C. Colonies were counted and recorded
whereas observed [6].
2) Passive air Sampling: Passive air sampling was done by settle plates petri dishes containing SCDM (Soyabean Casein Digest
agar Medium). Plates were opened and exposed for not less than 4 hours where lids of dishes were removed. After completion of
exposure, petri dishes were covered with lids, sealed with parafilm and send for incubation. Incubation of the petri dishes were
done for 72 hours at 20°C - 25°C and then for 48 hours at 30°C - 35°C. Colonies were counted and recorded whereas
observed[7].
3) Contact Plate Method: Surface sampling was performed with raised RODAC plates. Before testing any surface, it was to be
ensured that the area was dried. Contact plate were pressed onto the area in maximum contact site for 10 second by applying a
constant gentle force spread evenly over the whole contact plate without sliding and avoiding the creation of bubbles. After
contact with sample replace the lid and the area tested had been wiped down with isopropyl alcohol 70% to remove any residue
left by the contact plate. The contact plates were placed for 20°C - 25°C and then for 48 hours at 30°C - 35°C[8].
4) Swabbing Method: Swab samples were collected by removing a sterile swab from a sterile tube. The selected surface was
swabbed by moving the swab back and forth across the surface with several strokes at angle of 45 degree. The swab was rotated
during sampling to ensure that the entire surface of the swab was used. After sampling, the swab returned to its pre labelled
sampling tube containing liquid media. Swabs media was incubated at 20°C - 25°C and then for 48 hours at 30°C - 35°C.
5) Finger Dab: TSA (tryptone soya agar) used which was pre incubated for 48 hours. Before performing the test the operator was
ensured that the gloves were dried. Right/left finger with gloves of operator was placed on the surface of the plate firmly and
gentle pressure was applied for 5-10 seconds. The plates were closed and fingers were sanitized with sterile 70% isopropyl
alcohol. The plates were placed for 20°C - 25°C for 72 hours and then for 48 hours at 30°C - 35°C[9].
M8-10A M8-10 B
M8-3 M8-2 M8-1
Lyophilizer 2 Lyophilizer
D Man Entry
P Filling
Sealing B
Machine Machine
M8-10C M8-10D
Man Exit
Man Material Material Man Material Man
Material Airlock
M8-11
M8-5 Corridor M8-12
Autoclave
Corridor M8-13
Fig. 1 Schematic Layout of the Vaccine Filling area for Environment Monitoring
Table II Details of the Sampling Locations with Justification for Selection and Rational for Number of the Locations in Filling
Area[10].
No. of
Area Room Class Area(M2) Rational Justification
Locations
Filling and M8-1 A 6.78 4 1. Front side near filling needle o Near filling Machine there is
freeze 2. Back side near filling needle maximum chance of the
drying room 3. Front side left near working contamination by operator
4. Edge of the filling machine intervention.
near turn table
A 2.86 2 1. Front side right near working o Near filling machine there is
2. Edge of the Filling Machine maximum chance of the
near collection unit contamination by operator
intervention.
B 23.53 6 1. Near man entry o Near filling machine there is
2. Near return riser 1 maximum chance of the
3. Near return riser 2 contamination by operator
No. of
Area Room Class Area(M2) Rational Justification
Locations
4. Near filling station outside intervention.
LAF right side o Maximum chance of the
5. Near filling station outside contamination near return riser.
LAF left side o Near Lyophilizer loading maximum
6. Near Lyophilizer loading side man intervention occur so maximum
chances of contamination over there.
Person M8-9 C 6.44 4 7. Near entry door o Maximum chance of the
airlock 8. Near return riser contamination near return riser as it
of filling 9. Right hand right corner swipes out the contamination from
room 10. Right hand left corner clean room.
Material M8-8 C 4.39 3 1. In front corer o Maximum chance of the
airlock 2. Right hand right corner contamination near return riser as it
of filling 3. Right hand left corner swipes out the contamination from
room clean room.
Person M8-10a C 4.00 2 1. Near entry door o In grid fashion one location in each
Airlock1 2. Near return riser section so to cover uniformly overall
Person M8-10b C 4.00 2 1. Near entry door area.
Airlock2 2. Near return riser
Person M8-10c C 4.00 2 1. Near entry door
Airlock3 2. Near return riser
Person M8-10d C 4.00 2 1. Near entry door
Airlock4 2. Near return riser
Material M8-11 C 8.41 6 1. Near material entry door
airlock from 2. Near return riser
corridor 3. Entry side right corner
4. Entry side left corner
5. Exit side right corner
6. Exit side left corner
Module M8-12 C 36.14 10 1. In grid fashion. o In grid fashion one location in each
corridor 2. Entrance left side Four corner. section so to cover uniformly overall
3. Near return riser left side area as it is less critical area.
4. Near return riser right side o
5. Right side four corner.
Corridor M8-13 D 40.15 10 1. In grid fashion.
2. Entrance left side Four corner.
3. Near return riser left side
4. Near return riser right side
5. Right side four corner.
DPB M8-1 A 0.38 1 In centre o DPB is small in size at centre one
location is sufficient to represent
whole area of DPB.
M2: Meter square, M: Module room, LAF: Laminar Air Flow, DPB: Dynamic Pass Box,
V. ISOLATION OF MICROORGANISMS
Media are source to supply nutritional and growth requirement of microorganisms. From the environment monitoring study,
microorganisms are isolated and cultivated on selective medium based on their respective morphological and microscopic
characteristics.
Colony characteristics and Gram staining were done and as per the Gram staining’s results, plates were inoculated from the previous
growth on the plate during environment monitoring activity for 72 hours at 20-25 oC and then for 48 hours at 30°C - 35°C. Isolated
colony cultures was streaked on selective and enrichment medium for differential growth of the microorganisms. Biochemical test
were performed for all indivual isolated microorganism.
Enrichment media used are chocolate agar & Blood agar. Selective media used are Phenyl ethyl alcohol (PEA) agar, Mannitol salt
agar, MacConkey agar, Eosin methylene blue agar. Differential media used are Mannitol salt agar, MacConkey agar, Eosin
methylene blue agar.
12) Gelatin Hydrolysis Test: Inoculated a loopful of test culture into one of the tubes and the second tube was left uninoculated
(control) containing gelatin as substrate. Incubated both the tubes at 37oC for 24-72 hours. After incubation both the tubes were
placed at 5-10 °C in refrigerator for 30-60 minutes. After refrigeration, if liquefaction of gelatin would take place it confirmed
the presence of the gelatinase enzyme.
13) Lipid Hydrolysis Test: After inoculation of the test culture on the agar plate containing tributyrin as lipid substrate and
incubated at the 37°C for 24-72 hours, if clear zone of calcium carbonate solubilization was observed indicated bacteria
hydrolyse lipid and if colour would remained intact then it indicated no lipid utilization by bacteria.
14) Catalase Test: If bacteria possessed small amount of catalyse upon the additional of the hydrogen peroxide to the bacterial
isolates then oxygen would evolved. For this test a loopful of the test culture was inoculated in to the broth tube and incubated
at 37oC for 24-72 hours. After incubation, 1 ml of hydrogen peroxide was added over the growth in broth. Effervescence of
oxygen confirmed the presence of catalase.
15) Oxidase Test: In this test if the cytochrome oxidase is present then it catalyse the redox reaction between bacteria and dye
(tetramethyl-p-phenylenediamine dihydrochloride), so dye will reduce and deep violet colour is produced. Test organism was
grown on nutrient agar medium for 24 hours and filter paper strip was moisten with 3-4 drops of tetramethyl-p-
phenylenediamine dihydrochloride solution. Smear on filter paper with the help of sterile wire loop was made which showed
formation of violet colour after 10-15 seconds if oxidase would present.
16) Coagulase Test: Coagulase enzyme converts the soluble fibrinogen into insoluble fibrin which is used for identification of the
Coagulase positive and negative S.aureus bacteria. A well isolated colony was taken from the plate and a dense suspension
was prepared. A drop of thick suspension on slide was placed and loopful of oxalated plasma was added to a thick bacterial
suspension and stirred well. Clumping of cells within 5-10 seconds observed if coagulase would present.
Arrangement In pair, in tetrads Single, in chain In chain In cluster, single In cluster, in pair
Gram’s staining Gram positive Gram positive Gram positive Gram positive Gram positive
3) Results of Biochemical Tests: Five isolated species have different types of metabolic activities vary in their ability to hydrolyse
large molecules like carbohydrates, fats, and proteins as in table 8.
XII. ACKNOWLEDGEMENT
Hester Biosciences Limited, Quality Assurance, Quality Control, Production and Management team for providing the experimental
and technical support for the work execution.
REFERENCES
[1] Press Release, Market Watch News Department, At 17.4% CAGR, “Hybrid Smart Parking Platform Market Size Set to Register 2830 million USD by 2024”,
Aug. 12, 2020
[2] M. Vijay, “Law Relating to Drugs & Cosmetics, Twenty Sixth Edition, Eastern Book Company, Schedule C, pp. 360, July. 2018.
[3] General information, United States Pharmacopeia and national formulary, “Microbiological Control and Monitoring of Aseptic Processing Environments”,
Chapter, 1116, Vol. 1, USP 43, NF 38, 2020.
[4] T. Sandle, “Settle plate exposure under unidirectional airflow and the effect of weight loss upon microbial growth”, European Journal of Parenteral &
Pharmaceutical Sciences, 20(2), pp. 45-50, 2015.
[5] Schedule M, Drugs and Cosmetic Act 1940, Good manufacturing practices and requirements of premises, plant and equipments for pharmaceutical products,
ministry of health and family welfare (department of health and family welfare) notification, New Delhi, pp. 29, 5 Oct. 2018.
[6] S. A. Mohammed, S. M. Moselhy, E. E. Mostafa, “Microbiological environmental monitoring in pharmaceutical facility”, Egypt.Acad.J.biolog.Sci., Volume
3(1), pp. 63-64, 2011.
[7] M. A. Barbara. “Active Air vs. Passive Air (Settle Plate) Monitoring in Routine Environmental Monitoring Programs”, PDA Journal of Pharmaceutical
Science and Technology, 60 (6), pp. 350-355, Nov. 2006.
[8] J. Rastogi, F. Hashmi, “Brief Overview on Active Air Sampling Procedure for Environment Monitoring”, International Journal of Trend in Scientific Research
and Development (IJTSRD), Vol 3, 3, pp. 732-736, Mar-Apr. 2019.
[9] P. V. Ingle, K. Vivekanand, N. M. Bhatia, “Environmental Control for Parenteral Production”, Journal of Pharmaceutical Research & Clinical Practice, 4(3),
pp.22-32, July-Sept. 2014.
[10] World Health Organization, “Environmental Monitoring of Clean Rooms in Vaccine Manufacturing Facilities, Points to consider for manufacturers of human
vaccines, Vaccine Quality and Regulations (VQR), Quality, Safety, and Standards (QSS) Essential Medicines and Health Products (EMP),” Department World
Health Organization (WHO), Geneva, Switzerland, pp. 21-29, Nov. 2012.
[11] S. Robert, M. Jennifer, K. Rego, K. Romy, “Isolation, Characterization And Identification Of Environmental Bacterial Isolates With Screening For
Antagonism Against Three Bacterial Targets”, Technical Report No, NATICK/TR-17/014, April. 2017.
[12] G. Wu, X. Liu, “Characterization of predominant bacteria isolates from clean rooms in a pharmaceutical production unit”, J. Zhejiang Univ. - Sci. B, 8, pp.
666–672, 2007.
[13] L. Quinyuan, C. Xiu, J. Yi, J. Chenglin, “Cultural, physicological and Biochemical identification of actinobacteria”, Intechopen, pp.88-106, Feb. 2016.
[14] Using Biochemical Testing to Identify Bacteria, Available :
https://bio.libretexts.org/Bookshelves/Ancillary_Materials/Laboratory_Experiments/Microbiology_Labs/Microbiology_Labs_II/Lab_08%3A_Using_Biochem
ical_Testing_to_Identify_Bacteria.
[15] M. D. Gerald, R. A. Denver, Antiseptics and Disinfectants: Activity, Action, and Resistance, Clinical Microbiology Review, 14(1), pp. 227, Jan. 2001.